OncLive

Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO

AstraZeneca Readies New Portfolio of Targeted Cancer Therapies

New FDA-cleared AI tool could help predict if breast cancer will return

BioNTech’s mRNA cancer vaccine fails phase 3 test, significantly denting analysts’ confidence

This Pill Will Change Cancer Treatment Forever

Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal

Big tech says AI can find a cure for cancer. So where is it?

CBER official overruled review team’s rejection of new Replimune melanoma drug

FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

Silence Therapeutics aims at Takeda with new data in rare blood cancer

Ask An Expert: What You Need to Know About Lung Cancer Testing

Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits

8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

A breakthrough in pancreatic cancer has experts excited

7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

GLP-1 RAs May Reduce Metastatic Progression in Certain Obesity-Related Cancers

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026

Eli Lilly shares surge following a CHMP recommendation for Jaypirca's EU approval to treat chronic lymphocytic leukemia.

Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial